Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Maria Andrade of Cape Verde, Robert Mwanga of Uganda and American Jan Low, who all are from the Lima, Peru-based International Potato Center, and American Howarth Bouis of the international research group HarvestPlus were honored in a ceremony at the U.S. State Department. Kenneth M. Quinn, president of the World Food Prize Foundation, called their work "a breakthrough achievement in developing and implementing biofortification." He defined biofortification as "the process of breeding critical vitamins and micronutrients into staple crops, thereby dramatically reducing hidden hunger and improving health for millions and millions of people." The honorees' work has focused on the orange-fleshed sweet potato, an important source of vitamin A, especially in sub-Saharan Africa. Vitamin A deficiency, especially there and in Asia, is a cause of blindness and premature death, according to the International Potato Center, an agriculture research center based in Lima, Peru. "The impact of the work of all four winners will be felt around the globe but particularly in sub-Saharan Africa," said Gayle Smith, head of the U.S. Agency for International Development. The prize is awarded annually by the World Food Prize Foundation for food and agriculture innovation. The scientists will share the $250,000 prize equally and it will be awarded at a ceremony during World Food Prize week in Des Moines, Iowa, in October, when the prize will celebrate its 30th anniversary. Past recipients include John Kufuour, a former president of Ghana; former U.S. Senators Bob Dole and George McGovern; and Grameen Bank founder and Nobel laureate Dr. Muhammad Yunus of Bangladesh.
Sweet potato experts win World Food Prize.

There's no discussion of cost, even to mention that statins are relatively inexpensive these days and are mostly generically available. To its credit, the article does mention the cost of a calcium scan. We learn that "anywhere from 50 to 200 healthy people need to take a statin daily to prevent a single heart attack for five years." That's helpful information. It also notes that the observed benefit is less for older patients. The story could have added that even those numbers might disputed by some experts who perceive no meaningful benefit. For example, one review found being on a statin does not help people with low risk for heart disease live longer. The story does a service by highlighting the harms of statins. It explains: "The most common side effect of these drugs is muscle pain, which usually goes away if patients stop taking the medicines. People taking statins are also at a higher risk of developing diabetes, which is harder to reverse." It also mentions the potential for overtreatment with the use of coronary calcium scans. However, we wish it had included absolute numbers. The story says harms are "uncommon," but provides no data to back that up. Rates of adverse effects with statins have been measured at 1 to 10%, which makes them "common" in the definition of the European Medicines Agency. Also noteworthy is that some contend that adverse effects of statins have not been reliably reported. The story doesn't explain the quality of the study, or of studies on which current guidelines are based. We don't explicitly learn that this is a modelling study. In other words, this study consisted mostly of reinterpretations of math, not re-evaluations of real-life patients. The researchers said they were unable to obtain enough data on all possible harms and age-specific data on some harm outcomes, "so the risk thresholds we determined may still be too low." There is no disease-mongering here. This story includes sources that weren't involved in the study. The study's authors reported no conflicts of interest. The story could have acknowledged the influence of pharmaceutical companies in creating guidelines for statin use. The alternative of not taking a statin was the key message here, and that's laudable. However, we have a couple of concerns. First, we learn that "some statins were more effective than others, with atorvastatin (the generic name for Lipitor) being the best of the bunch." However, the story doesn't explain on what basis some statins are "more effective." In fact, some statins may be more effective at lower cholesterol, but the study found that no statin rises above others when it comes to the outcomes that counts most to patients reducing cardiovascular deaths. Also, the story doesn't mention lifestyle interventions diet and exercise. The story makes it clear that statins are widely prescribed. The story states this an attempt to better weigh the benefits and harms of statin use. There was a good range of interviewees with no reliance on a news release
Before Starting A Statin, Talk It Over With Your Doctor

In November 2018, a Grand Rapids, Michigan woman who needed a heart transplant due to complications from chemotherapy was turned down by a Spectrum Health medical committee due to lack of funds:Martin's son, Alex Britt, said she was diagnosed with breast cancer in 2005 and the chemotherapy treatment, while curing her cancer, damaged her heart to the extentthat she requires a transplant and had to leave her job on disability. Britt said she walked dogs and would pet-sit to raise funds.Martin said she was supposed to havea procedure Monday foran assistive device to help sustain her while waiting for a new heart. At the time,Martinhad already raised$4,600 on GoFundMefor her prior medical bills.Britt set up a newGoFundMepage to raise the additional$10,000needed to cover the cost of the immunosuppressivedrugs. The medical center reportedly would not consider Martin for a heart transplant without her being able to pay for the drugs.The letterto Hedda Martin reportedly said, in part:Your medical situation was presented to our multidisciplinary heart transplant committee on Tuesday, October 20, 2018. The decision made by the committee is that you are not a candidate at this time for a heart transplant due to needing a more secure financial plan for immunosuppressive medication coverage. The Committee is recommending a fundraising effort of $10,000.The story went viral when it was shared by Rep-Elect Alexandria Ocasio-Cortez (D-New York):Insurance groups are recommending GoFundMe as official policy where customers can die if they can't raise the goal in time but sure, single payer healthcare is unreasonable.h/t @DanRiffle pic.twitter.com/zetPW0MgDd Alexandria Ocasio-Cortez (@Ocasio2018) November 24, 2018The story is true. Spectrum Health acknowledged the letter in a lengthy statement on their official website, although the organization stopped short of discussing Martin's specific circumstances:It is important for patients to understand the long-term commitment they are making when accepting an organ donation. For this reason, we strive to ensure each patient is the best match so the donation contributes to a renewed life.Each transplant candidate is evaluated by our highly-skilled multidisciplinary team of physicians, nurses, social workers, clinical ethicists, dieticians and other experts. Transplant eligibility is a complex process. It requires consideration of a multitude of factors based on established best practice standards used by transplant centers across the country. Physical health, psychological and social well-being, and financial resources are among the factors considered for each patient. The ability to pay for post-transplant care and life-long immunosuppression medications is essential to increase the likelihood of a successful transplant and longevity of the transplant recipient. We help patients understand the long-term health implications of a transplant along with their total financial commitment, such as post-transplant medication expenses paid to pharmacies of their choice.Martin's GoFundMe has raised more than enough to cover the costs of the immunosuppressant medication she needs, but her story is far from unusual. At least a third of the money raised on GoFundMe in 2017 was to help with medical issues, because health care costs in the United States are so high:It's become a go-to way for people in need to help pay their doctors. Medical fundraisers now account for 1 in 3 of the website's campaigns, and they bring in more money than any other GoFundMe category, said GoFundMe CEO Rob Solomon."In the old paradigm you would give $20 to somebody who needed help," Solomon said. "In the new paradigm, you'll give $20, you'll share that and that could turn into 10, 20, 50 or 100 people doing that. So, the $20 could turn in hundreds, if not thousands, of dollars."Since at least 2017, a majority of Americans have listed access to affordable healthcare as one of their most pressing concerns.
A medical committee withheld a heart transplant from a woman saying that she needed to have at least $10,000 for immunosuppressant medication and suggested "a fundraising effort.